Home   >  
Angiogenesis/Protein Tyrosine Kinase
  >  
ALK
  >   Lorlatinib acetate
Lorlatinib acetate Chemical Structure

Lorlatinib acetate

Data Sheet For research use only. Not for human use.
Cat. No. :BCP23509CAS No. :1924207-18-0Purity:98%
 Tel: 0086-17754423994   or   orders@biochempartner.com
Real-Time Inquiry ×

* Required Fields.

Please complete the form below and you will get the price list in 1 minute.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Inquiry Online ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Bulk Inquiry ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

  • Publications Citing of Biochempartner's Lorlatinib acetate
  • Chemical Properties&Biological Activity
CAS No. 1924207-18-0 Cat. No. BCP23509
Name Lorlatinib acetate
Synonyms PF 06463922 acetate; PF-06463922 acetate; PF06463922 acetate;
SMILES
Chemical Name
Formula C23H23FN6O4 M. Wt 466.47
Purity 98% Storage Store at 4-8°C
Description PF-06463922 demonstrates significant cell activity against ALK and a large set of ALK clinical mutations with IC50 ranging from 0.2 nM-77 nM. PF-06463922 exhibited subnanomolar cellular potency against oncogenic ROS1 fusions and inhibited the crizotinib-refractory ROS1(G2032R) mutation and the ROS1(G2026M) gatekeeper mutation. Compared with crizotinib and the second-generation ALK/ROS1 inhibitors ceritinib and alectinib, PF-06463922 showed significantly improved inhibitory activity against ROS1 kinase. in vivo: PF-06463922 showed marked antitumor activity in tumor models expressing FIG-ROS1, CD74-ROS1, and the CD74-ROS1(G2032R) mutation. Furthermore, PF-06463922 demonstrated antitumor activity in a genetically engineered mouse model of FIG-ROS1 glioblastoma.
  • Quality Control&Technical Support
In the process of purchasing and using Biochempartner products, you can consult us if you have any problems: orders@biochempartner.com. We will try our best to solve all your doubts.

Recommend Products

More >

Tags:Lorlatinib acetate supplier,Lorlatinib acetate purchase,Lorlatinib acetate manufacturer,Lorlatinib acetate distributor,Lorlatinib acetate cost,Lorlatinib acetate buy,Lorlatinib acetate for sale

0086-13720134139